Creative Medical Technology Holdings (CELZ) Financials

$1.01

$-0.02 (-1.94%)

As on 28-Sep-2026 16:26EDT

Market cap

$7 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.7

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	0.00	0.01	0.01	0.01	0.09	0.09
Cost of Revenue	0.08	0.00	0.00	0.00	0.03	0.05
Gross Profit	-0.08	0.00	0.01	0.01	0.06	0.04
Operating Expenses	6.19	6.15	5.75	5.63	10.30	3.17
Operating Profit (EBIT)	-6.24	-6.14	-5.74	-5.62	-10.24	-3.13
Other Income	--	--	--	--	--	--
Profit before Tax	-6.04	-6.00	-5.49	-5.29	-10.14	19.21
Provision for Tax	0.00	--	--	0.00	-0.10	4.28
Profit after Tax (Net Income)	-6.04	-6.00	-5.49	-5.29	-10.14	19.21
Minority Interest	0.00	--	--	--	--	--
Consolidated Profit	--	--	--	--	--	19.21

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	8.65	7.51	6.34	10.34	15.86	10.22
Minority Interest	0.00	--	--	--	--	--
Non-Current Liabilities	--	--	--	--	3.27	0.76
Current Liabilities	0.70	0.28	0.33	0.37	3.32	1.05
Total Liabilities	10.08	7.81	6.67	10.72	19.19	11.27

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	0.36	0.41	0.53	0.44	0.44	0.53
Current Assets	9.02	7.40	6.14	10.27	18.75	10.74
Total Assets	10.08	7.81	6.67	10.72	19.19	11.27
Total Debt*	--	0.01	0.01	0.01	0.01	0.01
Net Current Assets	8.32	7.11	5.81	9.90	15.43	9.69

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-5.86	-5.30	-8.03	-7.80	-2.22
Cash Flow from Investing Activities	--	-0.05	6.32	3.45	-10.08	--
Cash from Financing Activities	--	7.17	1.45	-0.27	15.47	12.84
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-2.06	-2.52	-3.33	-3.81	-7.21	30.31
Cash EPS ($)	--	-2.46	-3.26	-3.74	-7.14	30.45
Adjusted Book Value ($)	--	3.15	3.84	7.45	11.27	16.12
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-2.46	-3.21	-5.78	-5.54	-3.50
Free Cash Flow per Share ($)	--	-2.46	-3.21	-5.85	-5.54	-3.50

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-86.36	-65.74	-40.30	-77.70	-133.50
ROE (%)	-74.74	-86.53	-65.85	-40.34	-77.78	-129.87
ROA (%)	-69.20	-82.81	-63.20	-35.36	-66.62	320.57
EBIT Margin (%)	-206,767.73	-102,380.23	-49,940.74	-58,739.71	-11,449.26	26,768.24
Net Margin (%)	-201,355.37	-99,916.80	-49,940.74	-58,739.71	-11,449.26	21,892.75
Cash Profit Margin (%)	-1.77	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	-50.00	-0.45	0.22	-0.90	0.01	-0.47
EBIT Growth (%)	-5.11	-11.82	-3.91	47.88	-143.18	166.93
Net Profit Growth (%)	-4.81	-9.13	-3.91	47.88	-152.80	152.89
EPS Growth (%)	35.14	0.24	0.13	0.47	-1.24	1.13
Book Value Growth (%)	-11.63	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-0.78	-0.69	-1.21	-0.05	0.07
Price / Book Value	0.71	0.62	0.60	0.62	0.03	0.14
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-1.45	0.42	0.39	0.69	1.78	-0.39
Close Price ($)	1.45	1.96	2.31	4.61	3.81	22.10
High Price ($)	6.25	6.90	10.28	14.20	51.45	650.00
Low Price ($)	0.80	1.50	1.96	3.60	3.30	15.83
Market Cap ($ Cr)	6.79	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.00	0.00	0.00	0.00	0.00
Short term debt to equity ratio	--	0.00	0.00	0.00	0.00	0.00
Current Ratio	12.91	25.97	18.73	27.65	5.64	10.22
Quick Ratio	12.73	25.97	18.72	27.64	5.64	10.21
Interest Coverage	--	--	--	--	-101.11	5.49

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	3,644.60	868.07	--	--	-11,375.41	2.83
Asset Turnover	0.00	0.00	0.00	0.00	0.01	0.01
Receivable days	--	3,170.61	--	-409,023.87	-20,769.23	5.17
Inventory Days	--	182.63	364.75	851.64	134.99	41.39
Payable days	--	45,299.66	24,521.97	181,854.83	25,828.13	4,238.21
Cash Conversion Cycle	--	-41,946.42	--	-590,027.06	-46,462.36	-4,191.65

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.